Confusing genes: a patient with MEN2A and Cushing's disease

Published on Jun 1, 2013in Clinical Endocrinology3.38
· DOI :10.1111/CEN.12072
Auditi Naziat2
Estimated H-index: 2
(Churchill Hospital),
Niki Karavitaki38
Estimated H-index: 38
(Churchill Hospital)
+ 7 AuthorsBrian Shine23
Estimated H-index: 23
(University of Oxford)
📖 Papers frequently viewed together
540 Citations
672 Citations
16 Authors (Gianluca Occhi, ..., Carla Scaroni)
92 Citations
#1Sandra Mastroianno (Casa Sollievo della Sofferenza)H-Index: 8
#2Massimo Torlontano (Casa Sollievo della Sofferenza)H-Index: 29
Last. Sebastiano Filetti (Sapienza University of Rome)H-Index: 73
view all 14 authors...
To describe the coexistence of mutations of both the multiple endocrine neoplasia type 1 (MEN1) and type 2 (MEN2) genes in a large Italian family and evaluate if it could be associated with more aggressive clinical manifestations of the two syndromes. Blood samples were obtained for genetic and biochemical analyses. The RET gene exons (8, 10, 11, 13, 14, 15, 16, 18) and the MEN1 coding regions, including the exon–intron boundaries, were amplified by PCR and directly sequenced. We identified two ...
14 CitationsSource
#1Andrea M. Isidori (Sapienza University of Rome)H-Index: 64
#2Andrea Lenzi (Sapienza University of Rome)H-Index: 83
Ectopic adrenocorticotropin secretion (EAS) accounts for 10-15% of cases of Cushing’s syndrome and comprises a spectrum of tumours from undetectable isolated lesions to widespread metastatic and agg
208 CitationsSource
#1André Lacroix (UdeM: Université de Montréal)H-Index: 66
#2Richard A. Feelders (EUR: Erasmus University Rotterdam)H-Index: 60
Last. Lynnette K. Nieman (NIH: National Institutes of Health)H-Index: 81
view all 4 authors...
Summary Chronic exposure to excess glucorticoids results in diverse manifestations of Cushing's syndrome, including debilitating morbidities and increased mortality. Genetic and molecular mechanisms responsible for excess cortisol secretion by primary adrenal lesions and adrenocorticotropic hormone (ACTH) secretion from corticotroph or ectopic tumours have been identified. New biochemical and imaging diagnostic approaches and progress in surgical and radiotherapy techniques have improved the man...
1,427 CitationsSource
Context: There are few large series of patients with ectopic, nonpituitary, corticotropin (ACTH) secretion (EAS). Objective: The objective of this study was to analyze the clinical, biochemical, and radiological features, management, and treatment outcome of patients with EAS. Design: This was a retrospective case-record study. Setting: The setting for this study was a tertiary referral hospital center. Patients: Forty patients with EAS were studied. Main Outcome Measures: Clinical, biochemical,...
463 CitationsSource
#1A. Brew AtkinsonH-Index: 18
Last. Brian SheridanH-Index: 29
view all 5 authors...
Summary Objective There have been a few reports on long-term remission rates after apparent early remission following pituitary surgery in the management of Cushing's disease. An undetectable postoperative serum cortisol has been regarded as the result most likely to predict long-term remission. Our objective was to assess the relapse rates in patients who underwent transsphenoidal surgery in order to determine whether undetectable cortisol following surgery was predictive of long-term remission...
310 CitationsSource
Context: Ectopic ACTH secretion (EAS) is difficult to diagnose and treat. We present our experience with EAS from 1983 to 2004. Setting: The study was performed at a tertiary care clinical research center. Patients: Ninety patients, aged 8–72 yr, including 48 females were included in the study. Interventions and Outcome Measures: Tests included 8 mg dexamethasone suppression, CRH stimulation, inferior petrosal sinus sampling (IPSS), computed tomography, octreotide scan, magnetic resonance imagin...
655 CitationsSource
#1Karin Frank-RaueH-Index: 32
#2Susanne RondotH-Index: 7
Last. Wieland Meng (University of Greifswald)H-Index: 10
view all 6 authors...
Context: Primary hyperparathyroidism (HPT) presents as a part of inherited syndromes such as multiple endocrine neoplasia (MEN) types 1 and 2. In patients with MEN1, parathyroid hyperplasia or multiple adenomas occur in approximately 90–95%. MEN2A-related HPT is characterized by a mild hypercalcemia, which is mostly asymptomatic. Objective: Here we present a family with coexistence of MEN1 gene mutation and RET mutation. Results: Six family members carrying MEN1 gene mutation IVS5 + 1G>A only, o...
22 CitationsSource
#1Jaroslaw P. Aniszewski (Mayo Clinic)H-Index: 2
#2William F. Young (Mayo Clinic)H-Index: 85
Last. Jon A. van Heerden (Mayo Clinic)H-Index: 85
view all 5 authors...
Gushing syndrome (CS) caused by ectopic adrenocorticotropic hormone (ACTH) production (EA) poses major challenges diagnostically by mimicking the pituitary-dependent form of CS and therapeutically by producing severe, life-threatening hypercortisolemia. This retrospective follow-up study describes the clinical characteristics and course of EA in a large referral center. Computer-based cross-index codes for EA, CS, and bilateral adrenalectomy were used to identify patients treated at the Mayo Cli...
260 CitationsSource
#1Annamaria Colao (University of Naples Federico II)H-Index: 116
Last. Gaetano LombardiH-Index: 110
view all 6 authors...
Objective: To evaluate the diagnostic accuracy of inferior petrosal sinus sampling (IPSS) in the differential diagnosis of ACTH-dependent Cushing’s syndrome as compared with pituitary imaging techniques. Design and Methods: We retrospectively studied the diagnostic accuracy of basal and post corticotropin-releasing hormone (CRH) IPSS, magnetic resonance imaging and computed tomography in distinguishing pituitary from ectopic ACTH secretion in 97 Cushing’s syndrome patients: 74 with Cushing’s dis...
139 CitationsSource
#1Jonas M. Sheehan (UVA: University of Virginia)H-Index: 17
#2M. Beatriz S. Lopes (UVA: University of Virginia)H-Index: 34
Last. Edward R. Laws (UVA: University of Virginia)H-Index: 124
view all 6 authors...
OBJECTIVE: Pathological confirmation of surgical resection of an adenoma for Cushing's disease is not always achieved. We reviewed our experience to determine the prognostic significance of this lack of confirmation regarding outcome, and we evaluate explanations for this situation. METHODS: The records of all patients undergoing transsphenoidal surgery for Cushing's disease from 1992 to 1998 were reviewed, and those with no histological confirmation of tumor were identified. Information regardi...
101 CitationsSource
Cited By19
#1Maria Luisa Brandi (UniFI: University of Florence)H-Index: 88
#2Sunita K. Agarwal (NIH: National Institutes of Health)H-Index: 48
Last. Rajesh V. Thakker (University of Oxford)H-Index: 95
view all 6 authors...
Multiple Endocrine Neoplasia Type 1 (MEN1), a rare tumor syndrome that is inherited in an autosomal dominant pattern, is continuing to raise great interest for endocrinology, gastroenterology, surgery, radiology, genetics and molecular biology specialists. There have been two major clinical practice guidance papers that were published in the past two decades, with the most recent publication 8 years ago. Since then, several new insights on the basic biology and clinical features of MEN1 have app...
2 CitationsSource
#1Judit DénesH-Index: 9
#2Márta Korbonits (QMUL: Queen Mary University of London)H-Index: 79
BACKGROUND Pituitary tumours are usually benign and relatively common intracranial tumours, with under- and overexpression of pituitary hormones and local mass effects causing considerable morbidity and increased mortality. While most pituitary tumours are sporadic, around 5% of the cases arise in a familial setting, either isolated [familial isolated pituitary adenoma, related to AIP or X-linked acrogigantism], or in a syndromic disorder, such as multiple endocrine neoplasia type 1 or 4, Carney...
1 CitationsSource
CONTEXT The characteristics of catecholamine-secreting pheochromocytomas have been well studied. However, less is known about the characteristics, management and outcome in patients with ectopic adrenocorticotropic hormone (ACTH) and/or corticotrophin releasing hormone (CRH)-secreting pheochromocytomas. OBJECTIVE To review the characteristics and outcomes of ACTH- and/or CRH-secreting pheochromocytomas. DATA SOURCE A systematic search of PubMed/MEDLINE and Web of Science, identifying relevant re...
2 CitationsSource
Abstract null null The 3PAs association describes the coexistence of pituitary adenoma, pheochromocytoma (PHEO), and paraganglioma (PGL). There are 90 3PAs cases reported in the literature (with and without genetic mutations/variants) since 1952. Most cases carry SDHx defects, whereas MEN1 and MAX are the second and third most common genes involved. Overall, pituitary adenomas in 3PAs with genetic defects are significantly more common among familial cases, more frequently macroadenomas secreting...
#1Adriana Albani (LMU: Ludwig Maximilian University of Munich)H-Index: 4
#2Marily Theodoropoulou (LMU: Ludwig Maximilian University of Munich)H-Index: 8
Last. Marily Theodoropoulou (LMU: Ludwig Maximilian University of Munich)H-Index: 34
view all 2 authors...
Abstract Pituitary tumors are monoclonal neoplasms whose pathogenesis is complex and still partly obscure. Germline mutations exist in around 5% of patients with pituitary tumors in isolated or syndromic settings. With the exception of AIP, which is mutated in 20% of young (
Cushing's disease (CD) is a multisystem disorder of a cortisol excess caused by ACTH -secreting pituitary tumor (corticotropinoma). CD in children is due to somatic or germline mutations with the late onset causing multiple endocrine tumors. If not treated, hypercortisolism leads to severe decrease in quality of life and life-threating conditions. The first-line treatment for CD is pituitary surgery, which might be followed by complications and relapse with necessity of additional surgery or ini...
#1Paraskevi Xekouki (University of Cambridge)H-Index: 2
#2Ana Brennand ('KCL': King's College London)H-Index: 5
Last. Constantine A. Stratakis (NIH: National Institutes of Health)H-Index: 107
view all 5 authors...
Pituitary adenomas (PA) and pheochromocytomas/paragangliomas (PHEO/PGL) are rare tumors. Although they may co-exist by coincidence, there is mounting evidence that genes predisposing in PHEO/PGL development, may play a role in pituitary tumorigenesis. In 2012, we described a GH-secreting PA caused by an SDHD mutation in a patient with familial PGLs and found loss of heterozygosity at the SDHD locus in the pituitary tumor, along with increased hypoxia-inducible factor 1α (HIF-1α) levels. Addition...
10 CitationsSource
#1Adriana AlbaniH-Index: 4
#2Luis G. Perez-RivasH-Index: 12
Last. Marily Theodoropoulou (LMU: Ludwig Maximilian University of Munich)H-Index: 34
view all 4 authors...
ABSTRACT Objective: Cushing disease is a rare severe condition caused by pituitary tumors that secrete adrenocorticotropic hormone (ACTH), leading to excessive endogenous glucocorticoid production. Tumors causing Cushing disease, also called corticotropinomas, are typically monoclonal neoplasms that mainly occur sporadically. Methods: Literature review. Results: Cushing disease is very rarely encountered in genetic familial syndromes. Oncogenes and tumor suppressor genes commonly associated with...
5 CitationsSource
#1Laura C Hernández-Ramírez (NIH: National Institutes of Health)H-Index: 14
#2Constantine A. Stratakis (NIH: National Institutes of Health)H-Index: 107
The knowledge on the molecular and genetic causes of Cushing’s syndrome (CS) has greatly increased in the recent years. Somatic mutations leading to overactive 3′,5′-cyclic adenosine monophosphate/protein kinase A and wingless-type MMTV integration site family/beta-catenin pathways are the main molecular mechanisms underlying adrenocortical tumorigenesis. Corticotropinomas are characterized by resistance to glucocorticoid negative feedback, impaired cell cycle control and overexpression of pathw...
7 CitationsSource